These results differed substantially from the ameliorating effects of CD treatment in NPC mice, which included a significant reduction of both cholesterol and GSL accumulation in treated Npc1−/− and Npc2−/− mice. This evidence concerns the gene CTSA and nasopharyngeal carcinoma.